| 0.846 | 0.005 | 0.846 | Caspase 9 stimulant | | |
| 0.736 | 0.003 | 0.736 | Amylase inhibitor | | |
| 0.712 | 0.019 | 0.712 | Transcription factor NF kappa B inhibitor | | |
| 0.627 | 0.016 | 0.627 | Antibacterial | | |
| 0.603 | 0.005 | 0.603 | Tubulin antagonist | | |
| 0.599 | 0.003 | 0.599 | Beta tubulin antagonist | | |
| 0.578 | 0.005 | 0.578 | Non-steroidal antiinflammatory agent | | |
| 0.614 | 0.05 | 0.614 | Antiinflammatory | | |
| 0.567 | 0.004 | 0.567 | Alpha tubulin antagonist | | |
| 0.572 | 0.016 | 0.572 | Spasmolytic | | |
| 0.602 | 0.049 | 0.602 | Apoptosis agonist | | |
| 0.583 | 0.03 | 0.583 | Cyclophilin D inhibitor | | |
| 0.468 | 0.017 | 0.468 | Tumour necrosis factor alpha release inhibitor | | |
| 0.456 | 0.02 | 0.456 | Hypoglycemic | | |
| 0.46 | 0.025 | 0.46 | Antioxidant | | |
| 0.434 | 0.002 | 0.434 | Topoisomerase II beta inhibitor | | |
| 0.439 | 0.016 | 0.439 | Angiogenesis stimulant | | |
| 0.448 | 0.041 | 0.448 | Vasodilator, peripheral | | |
| 0.45 | 0.047 | 0.45 | Immunosuppressant | | |
| 0.436 | 0.034 | 0.436 | Caspase 3 stimulant | | |
| 0.433 | 0.041 | 0.433 | Antithrombotic | | |
| 0.429 | 0.042 | 0.429 | Immunostimulant | | |
| 0.396 | 0.01 | 0.396 | Topoisomerase II inhibitor | | |
| 0.405 | 0.026 | 0.405 | Interleukin 2 agonist | | |
| 0.401 | 0.029 | 0.401 | Free radical scavenger | | |
| 0.377 | 0.005 | 0.377 | Expectorant | | |
| 0.459 | 0.093 | 0.459 | Alpha-glucosidase inhibitor | | |
| 0.377 | 0.027 | 0.377 | Antimitotic | | |
| 0.343 | 0.02 | 0.343 | Hepatoprotectant | | |
| 0.371 | 0.047 | 0.371 | Apoptosis antagonist | | |
| 0.35 | 0.032 | 0.35 | Nitric oxide antagonist | | |
| 0.323 | 0.018 | 0.323 | Peptidyltransferase inhibitor | | |
| 0.305 | 0.01 | 0.305 | Hexokinase inhibitor | | |
| 0.284 | 0.002 | 0.284 | Glycine receptor antagonist | | |
| 0.285 | 0.02 | 0.285 | NOS3 expression enhancer | | |
| 0.272 | 0.009 | 0.272 | Topoisomerase II alpha inhibitor | | |
| 0.269 | 0.007 | 0.269 | Selectin antagonist | | |
| 0.27 | 0.014 | 0.27 | Topoisomerase I inhibitor | | |
| 0.292 | 0.052 | 0.292 | Interleukin agonist | | |
| 0.29 | 0.061 | 0.29 | DNA damaging | | |
| 0.332 | 0.108 | 0.332 | Histamine release inhibitor | | |
| 0.304 | 0.084 | 0.304 | Vasodilator, coronary | | |
| 0.256 | 0.047 | 0.256 | Platelet adhesion inhibitor | | |
| 0.22 | 0.016 | 0.22 | Microtubule formation inhibitor | | |
| 0.246 | 0.044 | 0.246 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | | |
| 0.221 | 0.029 | 0.221 | Alpha-N-acetylglucosaminidase inhibitor | | |
| 0.253 | 0.067 | 0.253 | Vasodilator | | |
| 0.199 | 0.027 | 0.199 | Alkylator | | |
| 0.269 | 0.1 | 0.269 | Immunomodulator | | |
| 0.207 | 0.039 | 0.207 | Lipid peroxidase inhibitor | | |
| 0.238 | 0.07 | 0.238 | Cyclic AMP phosphodiesterase inhibitor | | |
| 0.234 | 0.079 | 0.234 | DNA synthesis inhibitor | | |
| 0.172 | 0.017 | 0.172 | AMP-activated protein kinase stimulant | | |
| 0.189 | 0.037 | 0.189 | Hemostatic | | |
| 0.26 | 0.116 | 0.26 | Angiogenesis inhibitor | | |
| 0.158 | 0.017 | 0.158 | Toll-Like receptor 4 antagonist | | |
| 0.169 | 0.035 | 0.169 | DNA intercalator | | |
| 0.142 | 0.018 | 0.142 | Transcription factor NF kappa B stimulant | | |
| 0.15 | 0.032 | 0.15 | Mucolytic | | |
| 0.178 | 0.063 | 0.178 | Thrombolytic | | |
| 0.17 | 0.055 | 0.17 | Protein kinase stimulant | | |
| 0.156 | 0.043 | 0.156 | Cyclooxygenase 3 inhibitor | | |
| 0.144 | 0.032 | 0.144 | Antineoplastic antibiotic | | |
| 0.172 | 0.062 | 0.172 | Interleukin 6 antagonist | | |
| 0.186 | 0.082 | 0.186 | Anesthetic general | | |
| 0.199 | 0.101 | 0.199 | RNA-directed DNA polymerase inhibitor | | |
| 0.106 | 0.009 | 0.106 | Carbonic anhydrase XIV inhibitor | | |
| 0.148 | 0.068 | 0.148 | Cell wall synthesis inhibitor | | |
| 0.119 | 0.044 | 0.119 | UDP-glucose 4-epimerase inhibitor | | |
| 0.106 | 0.032 | 0.106 | ATPase (Vacuolar H+) inhibitor | | |
| 0.091 | 0.019 | 0.091 | Neuraminidase inhibitor | | |
| 0.106 | 0.035 | 0.106 | Carbonic anhydrase XIII inhibitor | | |
| 0.081 | 0.011 | 0.081 | Alpha-mannosidase inhibitor | | |
| 0.09 | 0.02 | 0.09 | Neuraminidase (influenza) inhibitor | | |
| 0.073 | 0.005 | 0.073 | Antibiotic Aminoglycoside-like | | |
| 0.15 | 0.082 | 0.15 | Melanin inhibitor | | |
| 0.126 | 0.061 | 0.126 | DNA repair enzyme inhibitor | | |
| 0.082 | 0.019 | 0.082 | Protein 50S ribosomal subunit inhibitor | | |
| 0.174 | 0.114 | 0.174 | Hypolipemic | | |
| 0.159 | 0.104 | 0.159 | P-glycoprotein inhibitor | | |
| 0.119 | 0.066 | 0.119 | Cell adhesion inhibitor | | |
| 0.055 | 0.005 | 0.055 | Sodium/glucose cotransporter 2 inhibitor | | |
| 0.184 | 0.135 | 0.184 | Cardiotonic | | |
| 0.053 | 0.005 | 0.053 | Sodium/glucose cotransporter inhibitor | | |
| 0.055 | 0.007 | 0.055 | Protein 30S ribosomal subunit inhibitor | | |
| 0.059 | 0.013 | 0.059 | Neuraminidase (Influenza A) inhibitor | | |
| 0.139 | 0.094 | 0.139 | Interferon gamma antagonist | | |
| 0.059 | 0.018 | 0.059 | Mannosidase inhibitor | | |
| 0.036 | 0.004 | 0.036 | Ileal bile acid transport inhibitor | | |
| 0.106 | 0.077 | 0.106 | Photosensitizer | | |
| 0.094 | 0.066 | 0.094 | Phosphodiesterase 6D inhibitor | | |
| 0.076 | 0.048 | 0.076 | CDC25A inhibitor | | |
| 0.114 | 0.087 | 0.114 | Cyclooxygenase 2 inhibitor | | |
| 0.206 | 0.18 | 0.206 | Sodium/bile acid cotransporter inhibitor | | |
| 0.088 | 0.064 | 0.088 | Thioredoxin inhibitor | | |
| 0.033 | 0.009 | 0.033 | Toll-Like receptor 4 agonist | | |
| 0.132 | 0.11 | 0.132 | Heat shock protein 70 antagonist | | |
| 0.118 | 0.101 | 0.118 | Cyclooxygenase inhibitor | | |
| 0.058 | 0.041 | 0.058 | Lipocortins synthesis agonist | | |
| 0.142 | 0.125 | 0.142 | DNA methylase inhibitor | | |
| 0.069 | 0.057 | 0.069 | Histone deacetylase stimulant | | |
| 0.069 | 0.057 | 0.069 | Histone deacetylase SIRT1 stimulant | | |
| 0.135 | 0.123 | 0.135 | DNA methyltransferase I inhibitor | | |
| 0.149 | 0.139 | 0.149 | Neurotrophic factor enhancer | | |
| 0.048 | 0.043 | 0.048 | Glucose-6-phosphate translocase inhibitor | | |
| 0.03 | 0.028 | 0.03 | Melatonin 2 agonist | | |
| 0.094 | 0.093 | 0.094 | DNA polymerase I inhibitor | | |